301. Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex.
- Author
-
Lancioni A, Rotundo IL, Kobayashi YM, D'Orsi L, Aurino S, Nigro G, Piluso G, Acampora D, Cacciottolo M, Campbell KP, and Nigro V
- Subjects
- Animals, Blotting, Western, Fluorescent Antibody Technique, Mice, Mice, Inbred C57BL, Mice, Knockout, Models, Animal, Myocardium pathology, Myocardium ultrastructure, Physical Conditioning, Animal, Sarcoglycans metabolism, Dystrophin metabolism, Myocardium metabolism, Sarcoglycans deficiency
- Abstract
Cardiomyopathy is a puzzling complication in addition to skeletal muscle pathology for patients with mutations in β-, γ- or δ-sarcoglycan (SG) genes. Patients with mutations in α-SG rarely have associated cardiomyopathy, or their cardiac pathology is very mild. We hypothesize that a fifth SG, ε-SG, may compensate for α-SG deficiency in the heart. To investigate the function of ε-SG in striated muscle, we generated an Sgce-null mouse and a Sgca-;Sgce-null mouse, which lacks both α- and ε-SGs. While Sgce-null mice showed a wild-type phenotype, with no signs of muscular dystrophy or heart disease, the Sgca-;Sgce-null mouse developed a progressive muscular dystrophy and a more anticipated and severe cardiomyopathy. It shows a complete loss of residual SGs and a strong reduction in both dystrophin and dystroglycan. Our data indicate that ε-SG is important in preventing cardiomyopathy in α-SG deficiency.
- Published
- 2011
- Full Text
- View/download PDF